FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, Webinar, Feb. 11, 2014

The FDA’s focus on drug and devicemakers promotional activities is no longer limited to magazine and TV ads. They're looking at websites, Twitter, journal articles, TV appearances, Facebook and more.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
FDAnews

FDAnews

Falls Church, VA (PRWEB) January 27, 2014

The FDA is Watching:
What Twitter, Tradeshows and TV Have in Common
**FDAnews Webinar**
Feb. 11, 2014 — 12:00 p.m. – 1:30 p.m. EST
http://www.fdanews.com/FDAisWatching

There’s more: FDA officials have been seen walking the floors at medical meetings and industry trade shows, apparently on the lookout for improper promotional materials.

They’re checking the signage in booths … watching the promotional video messages … and listening to the physicians and other healthcare professionals paid to offer expertise or provide demos.

It's not much of a leap to begin to think that the FDA has probably created an electronic beehive of monitors and data to keep track of promotional activities of the drug and device markets.

Sound far-fetched?

Well, tell that to the drug company CEO who got slapped with a warning letter just days after making an appearance on CNBC. The warning letter said that comments the executive made on the television show constituted promotional speech and resulted in a misbranding of the company's product.

Many industry insiders have been shocked at the speed, detailed nature and the fact that the letter sent to the CEO was a warning letter rather than the typical untitled letter.
And all indications are that the FDA will continue this full-court press now — and in the future.

How can drug and devicemakers defend themselves?

By signing up TODAY to attend the FDAnews webinar The FDA Is Watching: What Twitter, Tradeshows and TV Have in Common, on Tuesday, Feb. 11, 2014. At this invaluable session, attendees will:

  •     Explore some of the more unique and challenging promotional pitfalls companies may encounter in 2014
  •     Discuss activities the FDA may now consider promotional that they traditionally did not
  •     Find out how the FDA’s recent enforcement actions should lead companies to reconsider and possibly modify their current approach to policies and training for both promotional and corporate and media communications
  •     Review checklists that can help vet trade show promotions – so that employees are ready and prepared if and when the FDA visits the booth
  •     Learn guidelines (and receive checklists) that will help improve communications with the media and media-type outlets, including social media
  •     Get new tools for developing a strong proactive legal strategy that will better protect companies by setting standards and safeguards to ensure claims are legally defensible
  •     Find out how to conduct a “gap analysis” of current compliance programs, plus learn ways to train personnel so they understand what claims are legal and safe to make, identify when claims can become dangerous, and know the difference

Take action now to get a clear understanding of what the FDA expects, the best legal strategy to respond to FDA accusations, and the most effective way to develop a preventive plan in-house.

Sign up today.

Meet the Presenters:
Timothy Ayers is a principal of Porzio, Bromberg & Newman in the Life Sciences Compliance, Commercialization and Regulatory Counseling Department. With a background as in-house counsel in the pharmaceutical/healthcare industry, he is familiar with the business challenges faced by members of corporate legal and compliance departments.

Michelle Axelrod is a principal at Porzio, Bromberg & Newman. Drawing from her in-house experience, Ms. Axelrod offers valuable insights to Porzio, Bromberg & Newman clients on corporate dynamics and provides innovative ideas to support business goals while effectively protecting companies and reducing organizational risk.

Who Will Benefit:

  •     Legal counsel
  •     Regulatory affairs
  •     Compliance officers
  •     Marketing and sales officers
  •     Product managers
  •     Advertising, marketing vendors

Conference Details
The FDA is Watching:
What Twitter, Tradeshows and TV Have in Common
**FDAnews Webinar**
Feb. 11, 2014 — 12:00 p.m. – 1:30 p.m. EST
http://www.fdanews.com/FDAisWatching

Tuition
$547 per site -- includes webinar registration and audio cds and transcripts

Easy Ways to Register
Online:     http://www.fdanews.com/FDAisWatching
By phone: 888-838-5578 or 703-538-7600

About FDAnews
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.